當前位置：杭州昊鑫生物科技股份有限公司>>云克隆>> PAA145Hu01血管內皮生長因子C(VEGFC)多克隆抗體
編號PAA145Hu01
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
來源多抗制備
宿主兔
效價-
Ig類型IgG
純化方式抗原特異性親和純化
標記物無標記物
免疫原RPA145Hu01-血管內皮生長因子C(VEGFC)重組蛋白
緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
性狀液體
濃度500µg/mL
且適物種Mus musculus (Mouse，小鼠)
應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。
下載英文說明書 中文說明書
規(guī)格20µl100µl 200µl 1ml 10ml
價格￥ 983
該抗體是針對VEGFC的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別VEGFC。
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有明顯的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
| 雜志 | 參考文獻 |
| Journal of Cellular Biochemistry | Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443] |
| genetics and molecular research | Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824] |
| Experimental and Therapeutic | Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498] |
| Am J Pathol | IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451] |
| PLoS One. | Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632] |
| Oncology Letters | RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth andinduces apoptosis in mouse breast cancer in vitro and in vivo. [pubmed:27895746] |
| Angiogenesis | Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235] |
| Oncology Reports | Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465] |
| LABORATORY INVESTIGATION | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289] |
| Cutaneous and Ocular Toxicology | Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957] |
注：產品僅用于科研
請輸入賬號
請輸入密碼
以上信息由企業(yè)自行提供，信息內容的真實性、準確性和合法性由相關企業(yè)負責，制藥網對此不承擔任何保證責任。
溫馨提示：為規(guī)避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
制藥網
松潘县|
宁波市|
织金县|
惠水县|
芮城县|
安化县|
西乡县|
图木舒克市|
浙江省|
吐鲁番市|
浮山县|
贵阳市|
汉寿县|
余姚市|
SHOW|
保亭|
阜宁县|
顺昌县|
巴彦县|
岳池县|
沁水县|
丰城市|
南岸区|
轮台县|
廊坊市|
壶关县|
舟曲县|
太白县|
宜良县|
德庆县|
济阳县|
博野县|
清苑县|
澄江县|
固始县|
宿迁市|
和田市|
加查县|
常州市|
长武县|
交城县|